Immunohistochemical absence of CD21 membrane receptor in nasopharyngeal carcinoma cells infected by Epstein-Barr virus in Spanish patients

被引:10
作者
Burgos, JS [1 ]
Vera-Sempere, FJ
机构
[1] Univ Autonoma Madrid, Fac Ciencias, CSIC, Ctr Biol Mol Severo Ochoa,CV Lab 203, E-28049 Madrid, Spain
[2] Univ Valencia, Hosp La Fe, Sch Med, Serv Pathol, Valencia, Spain
关键词
Epstein-Barr virus; nasopharyngeal carcinoma; non-isotopic in situ hybridization; PCR;
D O I
10.1097/00005537-200012000-00020
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/Hypothesis: The aim of this study was to analyze the relevance of the CD21 membrane receptor in nasopharyngeal carcinoma (NPC). CD21 is implicated in the introduction of the Epstein-Barr virus (EBV) genome into epithelial cells and B lymphocytes. Study Design: Immunohistochemical analysis of CD21 in NPC. Methods: Paraffin-embedded samples of NPC of different histological types with demonstrated presence of EBV were analyzed for CD21 expression using immunohistochemistry. Results: We detected EBV by non-isotopic in situ hybridization (NISH) and nested polymerase chain reaction (PCR) in 100% of samples, regardless of histological type, supporting the previous view that all the types of NPC are variants of an EBV-associated malignancy. CD21 was not detected in NPC, and this absence was a typical feature in our data group. Conclusions: The loss of the CD21 membrane receptor could be one of the immunophenotypical changes of the neoplastic cells that occur in the evolution of the NPC malignancy.
引用
收藏
页码:2081 / 2084
页数:4
相关论文
共 15 条
[1]   EPSTEIN-BARR VIRUS (EBV)-CONTAINING NASOPHARYNGEAL CARCINOMA-CELLS EXPRESS THE B-CELL ACTIVATION ANTIGEN BLAST2 CD23 AND LOW-LEVELS OF THE EBV RECEPTOR CR-2 [J].
BILLAUD, M ;
BUSSON, P ;
HUANG, D ;
MUELLERLANTZCH, N ;
ROUSSELET, G ;
PAVLISH, O ;
WAKASUGI, H ;
SEIGNEURIN, JM ;
TURSZ, T ;
LENOIR, GM .
JOURNAL OF VIROLOGY, 1989, 63 (10) :4121-4128
[2]   CHARACTERIZATION OF AN EPSTEIN-BARR-VIRUS RECEPTOR ON HUMAN EPITHELIAL-CELLS [J].
BIRKENBACH, M ;
XIAO, T ;
BRADBURY, LE ;
TEDDER, TF ;
KIEFF, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1405-1414
[3]   ESTABLISHMENT AND CHARACTERIZATION OF 3 TRANSPLANTABLE EBV-CONTAINING NASOPHARYNGEAL CARCINOMAS [J].
BUSSON, P ;
GANEM, G ;
FLORES, P ;
MUGNERET, F ;
CLAUSSE, B ;
CAILLOU, B ;
BRAHAM, K ;
WAKASUGI, H ;
LIPINSKI, M ;
TURSZ, T .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (04) :599-606
[4]   CD21-dependent infection of an epithelial cell line, 293, by Epstein-Barr virus [J].
Fingeroth, JD ;
Diamond, ME ;
Sage, DR ;
Hayman, J ;
Yates, JL .
JOURNAL OF VIROLOGY, 1999, 73 (03) :2115-2125
[5]   EPSTEIN-BARR VIRUS RECEPTOR OF HUMAN LYMPHOCYTES-B IS THE C3D RECEPTOR CR-2 [J].
FINGEROTH, JD ;
WEIS, JJ ;
TEDDER, TF ;
STROMINGER, JL ;
BIRO, PA ;
FEARON, DT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (14) :4510-4514
[6]  
GLASER R, 1980, JNCI-J NATL CANCER I, V64, P1085
[7]   Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells [J].
Imai, S ;
Nishikawa, J ;
Takada, K .
JOURNAL OF VIROLOGY, 1998, 72 (05) :4371-4378
[8]  
LIEBOWITZ D, 1994, SEMIN ONCOL, V21, P376
[9]   WHATS NEW IN HISTOLOGICAL CLASSIFICATION AND RECOGNITION OF NASO-PHARYNGEAL CARCINOMA (NPC) [J].
MICHEAU, C .
PATHOLOGY RESEARCH AND PRACTICE, 1986, 181 (02) :249-253
[10]   EPSTEIN-BARR-VIRUS PERSISTENCE AND VIRUS-ASSOCIATED TUMORS [J].
NIEDOBITEK, G ;
YOUNG, LS .
LANCET, 1994, 343 (8893) :333-335